Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 262-967-7 | CAS number: 61788-32-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / bone marrow chromosome aberration
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP-compliance study report, available as unpublished report, no restrictions, adequate for assessment
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 986
- Report date:
- 1986
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 475 (Mammalian Bone Marrow Chromosome Aberration Test)
- Principles of method if other than guideline:
- Method: other: SRI International method
- GLP compliance:
- yes
- Type of assay:
- chromosome aberration assay
Test material
- Reference substance name:
- Terphenyl, hydrogenated
- EC Number:
- 262-967-7
- EC Name:
- Terphenyl, hydrogenated
- Cas Number:
- 61788-32-7
- Molecular formula:
- C18Hn (n >18-36)
- IUPAC Name:
- Terphenyl, hydrogenated
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Fischer 344
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Simonsen Laboratories Inc., 1180C Day Road, Gilroy, CA 95020
- Weight at study initiation: 175-275 g
- Assigned to test groups randomly: yes
- Housing: two or three per cage
- Diet (e.g. ad libitum): ad libitum (Certified Purina Lab Chow (#5002C))
- Water (e.g. ad libitum): ad libitum (Purified water)
- Acclimation period: minimum 5 days
Administration / exposure
- Route of administration:
- intraperitoneal
- Vehicle:
- - Vehicle(s)/solvent(s) used: corn oil
- Lot/batch no. (if required): 790670 - Duration of treatment / exposure:
- Single administration
- Frequency of treatment:
- Not applicable
- Post exposure period:
- Immediately after test article administration, near the end of the working day and (when appropriate) each day thereafter prior to sacrifice.
Doses / concentrationsopen allclose all
- Dose / conc.:
- 0 mg/kg bw/day (nominal)
- Dose / conc.:
- 250 mg/kg bw/day (nominal)
- Dose / conc.:
- 1 250 mg/kg bw/day (nominal)
- Dose / conc.:
- 2 500 mg/kg bw/day (nominal)
- No. of animals per sex per dose:
- number of animals: 18 animals per sex per dose
number of animals per sampling time: 6 animals per sex per dose - Control animals:
- yes
- yes, concurrent vehicle
- Positive control(s):
- triethylenemelamine (TEM, CAS n° 51-18-3)
- Route of administration: intraperitoneal injection
- Doses / concentrations: 0.2 mg/kg TEM dissolved in Hanks' balanced salt solution.
- Lot/batch no.: 9558
Examinations
- Tissues and cell types examined:
- Target cells: bone marrow cells
- Details of tissue and slide preparation:
- CRITERIA FOR DOSE SELECTION:
Based on the dose range-finding and the pilot studies
TREATMENT AND SAMPLING TIMES ( in addition to information in specific fields):
sampling times: 6, 12, 24 hours after dosing
DETAILS OF SLIDE PREPARATION:
Slides were prepared by dropping cell suspensions onto water-dipped slides, passing the slides through the flame of an alcohol lamp several times, and checking the cell density using a phase-contrast microscope. If cell density was too thick, more fixation was added to dilute the suspension. Based on the amount of cell suspension, six or fewer slides were prepared from each tube.
The slides were placed in 7% Giemsa (Gurr's R66 in m/15 Sorensen's buffer, pH 6.8) for 5 to 20 min. rinsed in distilled water, soaked in xylene, and mounted with Permount to make permanent slides for scoring under bright-field or phase-contrast optics (100x oil objective). - Evaluation criteria:
- A test article was considered to have elicited a positive response in the in vivo bone marrow cytogenetic assay if either the mean aberrant cell frequency or the mean chromosomal aberration frequency per cell, or both, was significantly greater (P<0.05) in the test article-treated animals than in the negative control animals.
- Statistics:
- The following statistics were calculated for each animal: MI, the total number of chromosomal aberrations and the frequency of chromosomal aberrations per cell, the number and frequency of aberrations is each category, the number and frequency of cells with structurally aberrant chromosomes, the number and frequency of aneuploid (hyperploid) cells, the number and frequency of polyploid cells, and the number and frequency of several damaged cells.
These statistics have been analysed by the Bartlett's method, a one-way analysis of variance, the Dunnett's test and the Student's t-test.
Results and discussion
Test results
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- no effects
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- RESULTS OF RANGE-FINDING STUDY
- Dose range: 8, 40, 200, 1000 and 5000 mg/kg
- Clinical signs of toxicity in test animals:
At doses of 8, 40, 200 and 1000 mg/kg: There was no significant effect on body weight, no significant clinical signs of toxicity and no animals died.
At 5000 mg/kg: One male exhibited rough fur, humped backs, red exudate from the nose, slight diarrhea until it died. Another male exhibited rough fur and humped backs until the 14 days of the study.
At 5000 mg/kg: Females exhibited rough fur, humped backs, marked diarrhea and red exudate from the nose and the eyes. One female died.
RESULTS OF 24-HOUR PILOT STUDY
- Dose range: 0, 312, 625, 1250, 2500 and 5000 mg/kg
- Mitotic indices: no significant effect
- Clinical signs of toxicity in test animals:
At 2500 and 5000 mg/kg: Males and females exhibited negative changes in body weight, rough fur and humped backs.
No significant signs of toxicity were observed for animals treated with lower doses.
RESULTS OF 14-DAY PILOT STUDY
- Dose range: 312, 625, 1250, 2500 and 5000 mg/kg
- Clinical signs of toxicity in test animals:
At 5000 mg/kg: 4/5 males and 4/5 females died during the study. clinical signs of toxicity, rough fur, humped back, diarrhea, red exudates from the eyes and nose, slight hyperpnea
At 2500 mg/kg: weight gain reduction, clinical signs of toxicity, rough fur
RESULTS OF DEFINITIVE STUDY
- Clinical signs of toxicity in test animals:
At 250 mg/kg bw: no effects.
At 1250 mg/kg bw: a slight exudat from the left eye observed in one female.
At 2500 mg/kg bw: no effects; NOAEL.
Any other information on results incl. tables
Cytogenetic evaluation of bone marrow cells from female rats treated with Terphenyl, hydrogenated: 24-hour sacrifice
|
Negative control |
2500 mg/kg Terphenyl, hydrogenated |
0.2 mg/kg |
Number of animals |
5 |
4 |
5 |
Mitotic Index (Mean % ±) |
5.05 ± 0.44 |
6.36 ± 1.07 |
3.31 ± 0.34 |
Number of cells analyzed |
300 |
240 |
300 |
Number of aberrant cells (Mean % ±) |
0 |
2(0.83±0.83) |
85(28.33±5.75) |
Number of cells with structurally abnormal chromosomes (Mean % ±) |
0 |
2(0.83±0.83) |
82(27.33±5.52) |
Number of cells (%) with: |
|
|
|
Chromosome deletions |
0 |
0 |
1 (0.40) |
Chromosome exchanges |
0 |
0 |
0 |
Chromatid deletions |
0 |
2(0.83) |
27 (10.89) |
Chromatid exchanges |
0 |
0 |
12 (4.84) |
Aneuploidy |
0 |
0 |
2 (0.81) |
Polyploidy |
0 |
0 |
1 (0.40) |
Severe damage |
0 |
0 |
52 (17.33) |
Types of aberrations per cells: |
|
|
|
Overall frequency of aberrations (Mean % ±) |
0 |
3 (0.012) |
329(1.097±0.267) |
Chromosome deletions |
0 |
0 |
1 (0.004) |
Chromosome exchanges |
0 |
0 |
0 |
Chromatid deletions |
0 |
3 (0.012) |
51 (0.206) |
Chromatid exchanges |
0 |
0 |
14 (0.056) |
Number of cells (%) with: |
|
|
|
Chromatid gaps |
0 |
1 (0.42) |
4 (1.61) |
Chromosome gaps |
0 |
0 |
0 |
Cytogenetic evaluation of bone marrow cells from male rats treated with Terphenyl, hydrogenated: 24-hour sacrifice
|
Negative control |
2500 mg/kg Terphenyl, hydrogenated |
0.2 mg/kg |
Number of animals |
5 |
5 |
4 |
Mitotic Index (Mean % ±) |
5.82 ± 0.31 |
7.22 ± 0.98 |
4.79 ± 0.65 |
Number of cells analyzed |
300 |
300 |
300 |
Number of aberrant cells (Mean % ±) |
1(0.33±0.33) |
1(0.33±0.33) |
73(24.33±3.71) |
Number of cells with structurally abnormal chromosomes (Mean % ±) |
0 |
0 |
72(24.0±3.6) |
Number of cells (%) with: |
|
|
|
Chromosome deletions |
0 |
0 |
0 |
Chromosome exchanges |
0 |
0 |
1 (0.38) |
Chromatid deletions |
0 |
0 |
32 (12.08) |
Chromatid exchanges |
0 |
0 |
14 (5.28) |
Aneuploidy |
1 (0.33) |
0 |
1 (0.38) |
Polyploidy |
0 |
1 (0.33) |
0 |
Severe damage |
0 |
0 |
35 (11.67) |
Types of aberrations per cells: |
|
|
|
Overall frequency of aberrations (Mean % ±) |
1(0.003±0.003) |
1(0.003±0.003) |
257(0.857±0.112) |
Chromosome deletions |
0 |
0 |
0 |
Chromosome exchanges |
0 |
0 |
1 (0.004) |
Chromatid deletions |
0 |
0 |
65 (0.245) |
Chromatid exchanges |
0 |
0 |
15 (0.57) |
Number of cells (%) with: |
|
|
|
Chromatid gaps |
2 (0.67) |
0 |
7 (2.64) |
Chromosome gaps |
0 |
0 |
0 |
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results: negative
Terphenyl, hydrogenated does not induce chromosomal damage in male or female Fischer-344 rats under the conditions used in this study. - Executive summary:
This study assessed the ability of Terphenyl, hydrogenated administered by intraperitoneal injection to induce chromosomal damage in bone marrow cells of Fischer-344 rats. In the definitive study, rats were given Terphenyl, hydrogenated at doses of 0, 250, 1250, and 2500 mg/kg body weight. Groups of animals were sacrificed 6, 12, and 24 hr after treatment. The positive control groups received triethylenemelamine (0.2 mg/kg body weight 1 by intraperitoneal injection and were sacrificed 24 hr after treatment. Cells from animals exposed to 0 and 2500 mg/kg and those from animals in the positive control groups were evaluated microscopically for mitotic indexand chromosomal abnormalities. On the basis of the results, it was concluded that Terphenyl, hydrogenated does not induce chromosomal damage in male or female Fischer-344 rats under the conditions used in this study.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
